Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Sana Biotechnology Inc.
Headquarters: Seattle, WA, United States of America
Website: http://sana.com
Year Founded: 2018
Status: Public
Industry Sector: HealthTechnology
CEO: Steven D. Harr, MD
Number Of Employees: 194
Enterprise Value: $314,220,330
PE Ratio: -1.39
Exchange/Ticker 1: NASDAQ:SANA
Exchange/Ticker 2: N/A
Latest Market Cap: $366,790,816
BioCentury | Jan 22, 2025
Product Development
Vir, Sana gain new modality POC: BioCentury’s Clinical Report
Plus readouts from Jasper, Dyne and more
BioCentury | Jan 18, 2025
Product Development
2025 catalysts: New I&I indications take center stage
Inflammation and immunology readouts to define new priority indications, modality opportunities in immune reset
BioCentury | Dec 31, 2024
Management Tracks
Casdin to succeed Cox at Epirium
Plus: van Tilburg takes the helm at Renovaro and updates from Medicilon, Applied, Neurocentrx and more
BioCentury | Nov 13, 2024
Management Tracks
Rubedo names Frederick Beddingfield CEO
Plus: Kian Teik Beh succeeds Frederick Chew at A*STAR, and updates from Climb Bio, DiogenX, Arch, SR One and Koneksa
BioCentury | Sep 17, 2024
Management Tracks
Peter Maag resigns as Kyverna CEO
Plus: Ginkgo CEO Jason Kelly steps down from federal biotech advisory group, and updates from Lexicon, Arsenal, Ray and more
BioCentury | Sep 13, 2024
Management Tracks
Sana CFO Hardy to depart
Plus: New CEOs at Alchemab and Genespire, and more from Leyden and Pharmazz
BioCentury | Sep 9, 2024
Management Tracks
Doug Williams takes on CAR T cell access as TriArm CEO
Veteran of Biogen, Sana to head cross-border company TriArm Therapeutics
BioCentury | Aug 27, 2024
Management Tracks
Patel joins Sana as EVP, CSO
Plus: Ian Clements named CFO of Marea, new role at BII for Soni and more
BioCentury | Jul 19, 2024
Management Tracks
Remembering Lisa Burns, biotech’s ‘CEO whisperer’
An IR/PR pioneer, Burns connected CEOs, investors and analysts and played host to JPM’s best party
BioCentury | Apr 19, 2024
Management Tracks
Doug Williams leaving Sana
Plus: Baptista joins SmartCella and updates from LifeArc and Gain
Items per page:
1 - 10 of 81